| Stereochemistry | RACEMIC |
| Molecular Formula | C13H16N2O3 |
| Molecular Weight | 248.2777 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(C(=O)NC(=O)NC(C)=O)C1=CC=CC=C1
InChI
InChIKey=GBPZSCQLDXUGNO-UHFFFAOYSA-N
InChI=1S/C13H16N2O3/c1-3-11(10-7-5-4-6-8-10)12(17)15-13(18)14-9(2)16/h4-8,11H,3H2,1-2H3,(H2,14,15,16,17,18)
| Molecular Formula | C13H16N2O3 |
| Molecular Weight | 248.2777 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Acetylpheneturide (P-3981/Crampol) is used as an anticonvulsant in the treatment of epilepsy. It is usually used to treat convulsive attacks of epilepsy, psychomotor attacks and autonomic attacks. This medicine suppresses epileptic attacks by acting on the central nerves. The most commonly reported adverse reactions include generalized red rash.